Founded in 1993, SIRIO Pharma is a leading global nutraceutical solution provider with extensive expertise in an array of delivery formats, including gummies, softgels, capsules, tablets, powders, functional beverages, probiotics, and other innovative dosage forms. The company is one of the world’s largest providers of soft gel and gummy solutions. Driven by over 300 scientists across five global R&D centers, SIRIO transforms potent ingredients into effective, consumer-friendly products. The company’s commitment to quality is validated through numerous international certifications including China GMP, Australia's TGA, U.S. c-GMP, BRCGS, NSF, and Halal. SIRIO operates seven state-of-the-art manufacturing sites across China, Germany, and the United States—with a new facility in Thailand underway—delivering "global resources, local delivery" to partners in more than 50 countries. In 2023, SIRIO acquired Best Formulations, further solidifying its position as a premier global nutraceutical solution provider, and significantly enhancing its manufacturing capabilities and capacity – with a notable focus on bolstering its presence in North America.
